Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment-Reference-Cited by-同舟云学术

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

Published:2010-05 Issue:5 Volume:17 Page:345-351
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Lukasiewicz E.,Gorfine M.,Freedman L. S.,Pawlotsky J.-M.,Schalm S. W.,Ferrari C.,Zeuzem S.,Neumann A. U.,

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2009.01183.x/fullpdf

Reference33 articles.

1. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C;Wong;Am J Gastroenterol,2003

5. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon;Fattovich;J Hepatol,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A joint logistic regression and covariate-adjusted continuous-time Markov chain model;Statistics in Medicine;2017-07-10

2. Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children;Journal of Interferon & Cytokine Research;2016-01

3. Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents;Hepatic Medicine: Evidence and Research;2014-06

4. Individually Tailored Treatment Strategies in Treatment-naïve Chronic Hepatitis C Genotype 1 Patients;Advanced Therapy for Hepatitis C;2011-11-03

5. Baseline Prediction of Combination Therapy Outcome in Hepatitis C Virus 1b Infected Patients by Discriminant Analysis Using Viral and Host Factors;PLoS ONE;2010-11-30